Renal solute transporters and their relevance to serum urate disorder

Current Hypertension Reviews

Volumn 6, Issue 3, 2010, Pages 148-154

  Anzai, Naohiko ^a   Jutabha, Promsuk ^a   Endou, Hitoshi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gout; Hyperuricemia; Hypouricemia; PDZ; Transporter; Urate

Indexed keywords

ANION TRANSPORT PROTEIN; ANTIPORTER; BREAST CANCER RESISTANCE PROTEIN; GLUCOSE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 4; PROTEIN GLUT9; PROTEIN NPT4; PROTEIN OAT1; PROTEIN OAT10; PROTEIN OAT2; PROTEIN OAT3; PROTEIN OAT4; PROTEIN SMCT1; PROTEIN SMCT2; PROTEIN URAT1; SODIUM PHOSPHATE COTRANSPORTER; SODIUM PHOSPHATE COTRANSPORTER 1; UNCLASSIFIED DRUG; URIC ACID;

HUMAN; HYPOURICEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; URIC ACID BLOOD LEVEL;

EID: 77958031682     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340210791936732     Document Type: Review

References (44)

1. Anzai, N, Kanai Y, Endou H. New insights into renal transport ofurate. Curr Opin Rheumatol 2007; 19: 151-7.
2. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identificationof a renal urate anion exchanger that regulates blood uratelevels. Nature 2002; 417: 447-52.
3. Ekaratanawong S, Anzai N, Jutabha P, et al. Human organic aniontransporter 4 is a renal apical organic anion/dicarboxylateexchanger in the proximal tubules. J Pharmacol Sci 2004; 94: 297-304.
4. Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci 2006; 100: 411-26.
5. Jutabha P, Kanai Y, Hosoyamada H, et al. Identification of anovel voltage-driven organic anion transporter present at apicalmembrane of renal proximal tubule. J Biol Chem 2003; 278: 27930-8.
6. Gopal E, Fei YJ, Sugawara M, et al. Expression of slc5a8 in kidneyand its role in Na(+)-coupled transport of lactate. J Biol Chem 2004; 279: 44522-32.
7. Gopal E, Umapathy NS, Martin PM, et al. Cloning and functionalcharacterization of human SMCT2 (SLC5A12) and expression patternof the transporter in kidney. Biochim Biophys Acta 2007; 1768: 2690-7.
8. Bahn A, Hagos Y, Reuter S, et al. Identification of a new urate andhigh affinity nicotinate transporter, hOAT10 (SLC22A13). J BiolChem 2008; 283: 16332-41.
9. Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identifiedurate transporter influencing serum urate concentration, urate excretionand gout. Nat Genet 2008; 40: 437-42.
10. Anzai N, Ichida K, Jutabha P, et al. Plasma urate level is directlyregulated by a voltage-driven urate efflux transporter URATv1(SLC2A9) in humans. J Biol Chem 2008; 283: 26834-8.
11. Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB,Köttgen M. Identification of a urate transporter, ABCG2, with acommon functional polymorphism causing gout. Proc Natl AcadSci USA 2009; 106: 10338-42.
12. Anzai N, Miyazaki H, Noshiro R, et al. The multivalent PDZdomain-containing protein PDZK1 regulates transport activity ofrenal urate-anion exchanger URAT1 via its C terminus. J BiolChem 2004; 279: 45942-50.
13. Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecularanalysis of patients with renal hypouricemia in Japan-influence ofURAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15: 164-73.
14. Imaoka T, Kusuhara H, Adachi-Akahane S, et al. The renalspecifictransporter mediates facilitative transport of organic anionsat the brush border membrane of mouse renal tubules. J Am SocNephrol 2004; 15: 2012-22.
15. Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I. Involvement of uric acid transporter in increased renal clearance ofthe xanthine oxidase inhibitor oxypurinol induced by a uricosuricagent, benzbromarone. Drug Metab Dispos 2005; 33: 1791-5.
16. Ohtsu N, Anzai N, Fukutomi T, Kimura T, Sakurai H, Endou H. Human renal urate transporter URAT1 mediates the transportof salicylate. Nippon Jinzo Gakkai Shi (Japanese) 2010; 52: 489-504.
17. Shin HJ, Takeda M, Enomoto A, et al. Interactions of urate transporterURAT1 in human kidney with uricosuric drugs. Nephrology 2010 in press.
18. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterizationof a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004; 1681: 53-8.
19. Kikuchi R, Kusuhara H, Hattori N, et al. Regulation of tissuespecificexpression of the human and mouse urate transporter 1gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Mol Pharmacol 2007; 72: 1619-25.
20. Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associatedwith serum uric acid levels in Sardinia and Chianti cohorts. PLoSGenet 2007; 3: e194.
21. Döring A, Gieger C, Mehta D, et al. SLC2A9 influences uric acidconcentrations with pronounced sex-specific effects. Nat Genet 2008; 40: 430-6.
22. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF,Moley KH. Identification and characterization of human glucosetransporter-like protein-9 (GLUT9): alternative splicing alterstrafficking. J Biol Chem 2004; 279: 16229-36.
23. Bibert S, Hess SK, Firsov D, et al. Mouse GLUT9: evidencesfor a urate uniporter. Am J Physiol Renal Physiol 2009; 297: F612-9.
24. Dinour D, Gray NK, Campbell S, et al. Homozygous SLC2A9mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010; 21: 64-72.
25. Preitner F, Bonny O, Laverrière A, et al. Glut9 is a major regulatorof urate homeostasis and its genetic inactivation induces hyperuricosuriaand urate nephropathy. Proc Natl Acad Sci U S A 2009; 106: 15501-6.
26. Kimura H, Ichida K, Hosoyamada M, Oono I, Endou H, Hosoya T. Urate transport via hOAT4. Gout and Nucleic Acid Metabolism(Japanese) 2001; 25: 113-20.
27. Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A. Human renalorganic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 2007; 18: 430-9.
28. Sato M, Iwanaga T, Mamada H, et al. Involvement of uric acidtransporters in alteration of serum uric acid level by angiotensin IIreceptor blockers. Pharm Res 2008; 25: 639-46.
29. Ichida K, Hosoyamada M, Kimura H, et al. Urate transport viahuman PAH transporter hOAT1 and its gene structure. Kidney Int 2003; 63: 143-55.
30. Eraly SA, Vallon V, Rieg T, et al. Multiple organic anion transporterscontribute to net renal excretion of uric acid. Physiol Genomics 2008; 33: 180-92.
31. Sato M, Mamada H, Anzai N, Shirasaka Y, Nakanishi T, Tamai I. Renal secretion of uric acid by organic anion transporter 2(OAT2/SLC22A7) in human. Biol Pharm Bull 2010; 33: 498-503.
32. Kimura H, Ichida K, Hosoyamada M, Oono I, Endou H, Hosoya T. Aalysis of uric acid transport via hOAT3. Gout and Nucleic AcidMetabolism (Japanese) 2000; 24: 115-21.
33. van Aubel, RA, Smeets PH, van den Heuvel JJ, Russel FG. Humanorganic anion transporter MRP4 (ABCC4) is an efflux pump forthe purine end metabolite urate with multiple allosteric substratebinding sites. Am J Physiol Renal Physiol 2005; 288: F327-33.
34. El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. Effect of hypouricaemic and hyperuricaemic drugs on therenal urate efflux transporter, multidrug resistance protein 4. Br JPharmacol 2008; 155: 1066-75.
35. Dehghan A, Köttgen A, Yang Q, et al. Association of three geneticloci with uric acid concentration and risk of gout: a genome-wideassociation study. Lancet 2008; 372: 1953-61.
36. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biologyand medicine. Annu Rev Pharmacol Toxicol 2006; 46: 381-410.
37. Ishikawa T, Nakagawa H. Human ABC transporter ABCG2 incancer chemotherapy and pharmacogenomics. J Exp Ther Oncol 2009; 8: 5-24.
38. Uchino H, Tamai I, Yamashita K, et al. p-aminohippuric acidtransport at renal apical membrane mediated by human inorganicphosphate transporter NPT1. Biochem Biophys Res Commun 2000; 270: 254-9.
39. Urano W, Taniguchi A, Anzai N, et al. Sodium-dependent phosphatecotransporter type 1 (NPT1) sequence polymorphisms inmale patients with gout. Ann Rheum Dis 2010; 69: 932-3.
40. Anzai N, Endou H. Drug discovery for hyperuricemia. Expert OpinDrug Discov 2007; 2: 1251-61.
41. Miyauchi S, Gopal E, Fei YJ, Ganapathy V. Functional identificationof SLC5A8, a tumor suppressor down-regulated in colon cancer,as a Na(+)-coupled transporter for short-chain fatty acids. JBiol Chem 2004; 279: 13293-6.
42. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am 2006; 32: 313-31.
43. Thangaraju M, Ananth S, Martin PM, et al. c/ebpdelta Null mouseas a model for the double knock-out of slc5a8 and slc5a12 inkidney. J Biol Chem 2006; 281: 26769-73.
44. Kolz M, Johnson T, Sanna S, et al. Meta-Analysis of 28,141individuals identifies commonvariants within five new loci thatinfluence uric acid concentrations. Plos Genet 2009; 5: 1-10.